Search for Clinical Trials

The START study is a multicenter randomized, placebo-controlled Phase 2 study designed to evaluate the efficacy and safety of two doses of an…
  • Alzheimer's Disease
ACCLAIM-Lp(a) is a clinical research study for people who have or are at risk for heart disease, stroke, or peripheral artery disease. Lipoprotein(a…
  • Heart
  • Lipids and Cholesterol
  • Vascular
Nmra-335140-301 (Koastal-1) A Phase 3, Randomized, Double-blind, Placebo-controlled Study To Evaluate The Effects Of Oral Nmra-335140 Versus Placebo…
  • Depression and Mood Disorders
  • Psychiatry and Behavior
PTSD is a debilitating condition with poorly understood physiology. Through the use of medical imaging, we seek to visualize AMPA receptor density…
  • Depression and Mood Disorders
  • Psychiatry and Behavior
Study to Demonstrate the Value of Time-Varying Patterns for Spinal Cord Stimulation in the Treatment of Chronic PainThe goal of this study is to…
  • Brain/Spinal Cord/Nervous System
Researchers at the Children's Nutrition Research Center at Baylor College of Medicine are looking for parents and their 10-12-year-olds to…
  • Healthy Volunteers - Child
  • Nutrition
  • Pediatrics
A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to determine the Efficacy and Safety of LASN01 in Patients with…
  • Eye and Vision
Combination of Induction Durvalumab and Tremelimumab alone versus Durvalumab and Tremelimumab with chemotherapy for Potentially Resectable Pleural…
  • Cancer - Lung
  • Cancer - Metastatic
  • Lung
Through this research study, individuals ages 45-69 may qualify for a free cancer screening, not yet available to the public. Have questions?…
  • Cancer - Cervical
  • Cancer - Colon/Rectal
  • Cancer - Head/Neck
  • Ear/Nose/Throat
  • Head and Neck
  • Healthy Volunteers - Adult
VRDN-001-301 A randomized, double-masked, placebo-controlled safety, tolerability, and efficacy study of VRDN-001, a humanized monoclonal antibody…
  • Endocrinology
  • Eye and Vision
Back to topback-to-top